Cell BioEngines LLC

We Develop Cell-based Products Both Within Our Company and Through Our Partner Company. We are therapeutic area agnostic which allows us maximum flexibility to focus on advancing cutting-edge cell-based immuno-therapeutics approaches in oncology across multiple types of solid cancer. Cell BioEngines, Inc., is a clinical-stage biotech company focused on developing 'off-the-shelf' allogeneic cell therapies as 'drugs' to turn all cancers into curable diseases. Established in December 2022, the company's revolutionary science includes single cell discoveries from Harvard Medical School, and in-licensing manufacturing process technology from Icahn School of Medicine at Mount Sinai. Stem Cells Expansion and Differentiation to Manufacture Potent Cells for Clinical Use. Cellular Immunotherapy Product Candidates to Transform Medicine and Healthcare. Allows us to pursue a broad range of products and product candidates with high clinical and commercial potential. Low cost manufacturing enables us to act quickly to seize time-sensitive opportunities and provides us with a wider range of options from which to select the most ideal financial structure for each product.